Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...

(Reuters) -Pfizer and Moderna on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate responses to U.S. President Donald Trump's demand that ...

Pfizer delivered a significant earnings surprise in its third-quarter results, demonstrating the pharmaceutical giant’s resilience amid a challenging year for its stock performance. The company’s ...

A new emerging study shows that COVID-19 mRNA vaccines like Pfizer and Moderna shots may help fight cancerous tumours by reviving the immune system. Researchers from the MD Anderson Cancer Center in ...

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy. On August 12, Pfizer and Astellas Pharma reported that their combination therapy for muscle-invasive bladder cancer had positive ...

Pfizer is one of the largest pharmaceutical companies on the planet. It has a proven track record of finding, developing, and commercializing new drugs. The recent price advance is worth paying ...

(Reuters) -Pfizer said on Wednesday its COVID-19 vaccine has saved more than 14 million lives worldwide, after U.S. President Donald Trump urged pharmaceutical companies to justify the success of ...

Pfizer Inc. (NYSE: PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions ...

If I am a Pfizer Inc. (PFE) investor (I used to be, nonetheless), I should have been "elated" at PFE's recent performance against the market, while still getting rewarded with a forward yield that ...